Prognostic significance of gross extrathyroidal extension invading only strap muscles in differentiated thyroid carcinoma
Sign Up to like & getrecommendations! Published in 2018 at "British Journal of Surgery"
DOI: 10.1002/bjs.10830
Abstract: In the eighth edition of the AJCC staging system for differentiated thyroid carcinoma (DTC), minimal extrathyroidal extension (ETE) is no longer a determinant of T3 category. Instead, gross ETE invading only strap muscles has been… read more here.
Keywords: extrathyroidal extension; invading strap; differentiated thyroid; strap muscles ... See more keywords
Use of multikinase inhibitors/lenvatinib concomitant with antiresorptive therapy for bone metastases from radioiodine‐resistant differentiated thyroid cancer
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4983
Abstract: Bone is the second most common distant metastasis site in differentiated thyroid cancer (DTC) and is normally associated with the presence of other metastases, which are usually radioiodine‐resistant. The presence of bone metastasis (BM) determines… read more here.
Keywords: differentiated thyroid; bone; therapy; radioiodine resistant ... See more keywords
Use of multikinase inhibitors/lenvatinib concomitant with radioiodine for the treatment of radioiodine refractory differentiated thyroid cancer
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5105
Abstract: Thyroid cancer is the most frequent endocrine tumor. However, in locally advanced or metastatic disease we have only two types of treatment at our disposal: radioactive iodine (RAI) when the disease is RAI‐sensitive and multikinase… read more here.
Keywords: radioiodine; multikinase inhibitors; differentiated thyroid; thyroid cancer ... See more keywords
Use of multikinase inhibitors/lenvatinib in patients with synchronous/metachronous cancers coinciding with radioactive‐resistant differentiated thyroid cancer
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5107
Abstract: This review focuses on patients with differentiated thyroid carcinoma (DTC) associated with multiple primary malignant neoplasm (MPMN) treated by multikinase inhibitors (MKIs) as systemic treatment for advanced disease. Despite the increasing frequency of MPMNs (many… read more here.
Keywords: use multikinase; multikinase inhibitors; inhibitors lenvatinib; differentiated thyroid ... See more keywords
Use of multikinase inhibitors/lenvatinib in patients with high cardiovascular risk/vasculopathy and radioiodine refractory‐differentiated thyroid cancer
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5127
Abstract: Antiangiogenic tyrosine kinase inhibitors are the treatment of choice in radioiodine refractory‐differentiated thyroid cancer (RR‐DTC). Nevertheless, these therapies present class toxicities that may impact their feasibility and patient's quality of life. Their mechanism of action… read more here.
Keywords: refractory differentiated; differentiated thyroid; thyroid cancer; radioiodine refractory ... See more keywords
Concordance in postsurgical radioactive iodine therapy recommendations between Watson for Oncology and clinical practice in patients with differentiated thyroid carcinoma
Sign Up to like & getrecommendations! Published in 2019 at "Cancer"
DOI: 10.1002/cncr.32166
Abstract: To the authors' knowledge, the indications for radioactive iodine (RAI) therapy in patients with differentiated thyroid carcinoma (DTC) are unclear; treatment decisions are based on physician judgment. The objective of the current study was to… read more here.
Keywords: patients differentiated; radioactive iodine; differentiated thyroid; thyroid carcinoma ... See more keywords
B3 thymoma mimicking poorly differentiated thyroid carcinoma: Diagnostic pitfalls of anterior mediastinal mass fine needle aspiration
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostic Cytopathology"
DOI: 10.1002/dc.25075
Abstract: B3 thymoma is a rare malignant type of thymic epithelial neoplasm found in the anterior mediastinum. Diagnosis of thymoma from fine needle aspiration (FNA) can be challenging due to the infrequency of sampling and its… read more here.
Keywords: thyroid carcinoma; differentiated thyroid; thymoma; poorly differentiated ... See more keywords
Perception of risk and treatment decisions in the management of differentiated thyroid cancer.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of surgical oncology"
DOI: 10.1002/jso.26858
Abstract: BACKGROUND AND OBJECTIVES The recent de-escalation of care for differentiated thyroid cancer (DTC) has broadened the range of initial treatment options. We examined the association between physicians' perception of risk and their management of DTC.… read more here.
Keywords: cancer; risk; differentiated thyroid; treatment ... See more keywords
Utility of sonography for identifying metastatic cervical adenopathy in children with differentiated thyroid carcinoma at presentation
Sign Up to like & getrecommendations! Published in 2020 at "Pediatric Radiology"
DOI: 10.1007/s00247-020-04804-z
Abstract: No study has evaluated the diagnostic accuracy of sonography for the depiction of metastatic cervical adenopathy in children with differentiated thyroid carcinoma at presentation or determined which sonographic features are most useful. To evaluate the… read more here.
Keywords: metastatic cervical; differentiated thyroid; thyroid carcinoma; sonography ... See more keywords
Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population
Sign Up to like & getrecommendations! Published in 2018 at "Langenbeck's Archives of Surgery"
DOI: 10.1007/s00423-018-1657-2
Abstract: BackgroundInternational guidelines for the management of differentiated thyroid cancers are based on the 7th TNM classification: pT3 tumors are defined as differentiated thyroid cancers (DTCs) measuring more than 4 cm in their greatest dimension that are… read more here.
Keywords: pt3d; risk; recurrence; pt3 ... See more keywords
[Current controversies in risk-adapted therapy in differentiated thyroid cancer: Is less (therapy) really more?]
Sign Up to like & getrecommendations! Published in 2019 at "Wiener medizinische Wochenschrift"
DOI: 10.1007/s10354-019-00713-5
Abstract: In recent years, there has been worldwide a significant (relative) increase in "small" thyroid cancer (pT1 = tumor size of ≤10 mm), which has now reached a plateau. This fact and the absence of prospective and randomized clinical trials are… read more here.
Keywords: therapy; differentiated thyroid; thyroid cancer; cancer ... See more keywords